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Background
Loco-regional relapses (LRRs) from rectal cancer still rep-
resent a major issue in colo-rectal surgery. With the intro-
duction of Total Mesorectal Excision (TME), LRR
incidence after curative resection for rectal cancer dramat-
ically decreased from 20–40% of cases to 2–12%. Several
factors are involved in predicting LRRs, the most impor-
tant of these being Dukes stage. When no treatment is per-
formed, median survival for these patients is about 8
months.
In 50% of cases LRRs are confined to the pelvis; so, the
recurrent tumour can be amenable to potentially curative
surgical removal, with minimal mortality and a 5 year sur-
vival rate around 20–40%. Surgery is not recommended
for patients with unresectable metastases and/or infiltra-
tion of sciatic nerve, sacrum above S2–S3, and pelvic
bones.
We hereby report our personal experience with manage-
ment of LRRs from rectal cancer.
Materials and methods
We retrospectively reviewed the clinical records of 289 rec-
tal cancer patients, treated with curative resection between
1998 and 2007. Patients were divided in two groups: A
(206 patients), younger than 74 y.o.; and B (83 patients),
older than 75 years old. A total of 31 patients (10.7%)
developed a LRR: 24 patients of group A (11.6%) and 7 of
group B (8.4%). We also included in the study 11 patients
(8 in group A, 3 in group B) treated elsewhere for the pri-
mary; we thus managed in total 42 LRR patients (26
males, 16 females; mean age 64 y.). LRR was anastomotic
in 37.1% of cases, central-pelvic in 31.4%, presacral in
25.7% and perineal in 5.7%. In 88.5% of patients a R0
resection had been achieved at former surgery. Mean DFS
was 13.4 months.
We focused on the 35 patients assessed as metastases-free
at the time of the first surgery.
Results
Surgical management with curative intention was possi-
ble for 23 patients (65.7%), 17 of which in group A, and
consisted either of exeresis of the recurrent neoplasm (10
cases), re-resection (7 cases) or Miles operation (6 cases).
In18 of these patients (15 of group A) a R0 resection was
achieved. Postoperative morbidity was 42.8%; periopera-
tive mortality was 7.1%. 3 years – OS was 28%, but it was
60% for R0 patients.
Conclusion
In selected patients, especially if younger than 75, LRRs
may be amenable to a multimodal approach that, in a rel-
evant rate of cases, can lead to a potentially curative R0
resection; for the other cases a palliative management is
possible, to improve overall survival and quality of life.
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